A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma

Objective. To screen the cell differentiation trajectory-related genes and build a cell differentiation trajectory-related signature for predicting the prognosis of lung adenocarcinoma (LUAD). Methods. LUAD single cell mRNA expression profile, TCGA-LUAD transcriptome data were obtained from GEO and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fan Yang, Yan Zhao, Xiaohan Huang, Jin Zhang, Ting Zhang
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Genetics Research
Online Access:	http://dx.doi.org/10.1155/2022/3483498
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma
by: Wei Wang, et al.
Published: (2021-01-01)

Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma
by: Zihao Sun, et al.
Published: (2025-01-01)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
by: Jin Xu, et al.
Published: (2022-01-01)

A Novel Ferroptosis-Related Gene Signature for Prognosis Prediction in Ewing Sarcoma
by: Runhan Zhao, et al.
Published: (2022-01-01)

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01)

A telomere-related signature for predicting prognosis and assessing immune microenvironment in osteosarcoma
by: Shihao Li, et al.
Published: (2025-01-01)

Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma
by: Lu Liang, et al.
Published: (2022-01-01)

Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma
by: Juan Peng, et al.
Published: (2024-01-01)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
by: Xiangjun Qi, et al.
Published: (2022-01-01)

Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA
by: Jun-Yu Zhu, et al.
Published: (2022-01-01)

Construction of a circadian rhythm-related gene signature for predicting the prognosis and immune infiltration of breast cancer
by: Lin Ni, et al.
Published: (2025-02-01)

The Expression of PPAR Pathway-Related Genes Can Better Predict the Prognosis of Patients with Colon Adenocarcinoma
by: Xiao-Yu Zhou, et al.
Published: (2022-01-01)

GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma
by: Lin Ni, et al.
Published: (2023-01-01)

Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients
by: Zihan Zhu, et al.
Published: (2023-01-01)

Multiomic machine learning on lactylation for molecular typing and prognosis of lung adenocarcinoma
by: Mengmeng Hua, et al.
Published: (2025-01-01)

A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma
by: Xing Jin, et al.
Published: (2022-01-01)

Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
by: Ziyi Zhou, et al.
Published: (2025-02-01)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
by: Zhengyang Fan, et al.
Published: (2023-01-01)

Whole slide image based deep learning refines prognosis and therapeutic response evaluation in lung adenocarcinoma
by: Tao Chen, et al.
Published: (2025-01-01)

DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration
by: Yanni Xu, et al.
Published: (2020-01-01)

Identification of a Ferroptosis-Related Signature Associated with Prognosis and Immune Infiltration in Adrenocortical Carcinoma
by: Xi Chen, et al.
Published: (2021-01-01)

Lipid Metabolism-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Advanced Gastric Cancer
by: Lijian He, et al.
Published: (2024-01-01)

A Golgi apparatus‑related subtype and risk signature predicts prognosis and evaluates immunotherapy response in gastric cancer
by: Ruyue Chen, et al.
Published: (2025-01-01)

Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
by: Meifang Li, et al.
Published: (2025-02-01)

Correlation between Ferroptosis-Related Gene Signature and Immune Landscape, Prognosis in Breast Cancer
by: Jiahao Zhu, et al.
Published: (2022-01-01)

Multiphoton imaging-based quantifiable collagen signatures for predicting outcomes in patients with pancreatic ductal adenocarcinoma
by: Xiwen Chen, et al.
Published: (2025-02-01)

A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features
by: Zhen‐Zhong Zhou, et al.
Published: (2025-01-01)

Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients
by: Dahua Xu, et al.
Published: (2024-01-01)

EXO1 is a key gene for lung-resident memory T cells and has diagnostic and predictive values for lung adenocarcinoma
by: Zhuoqi Li, et al.
Published: (2025-02-01)

Hypoxia signature derived from tumor-associated endothelial cells predict prognosis in gastric cancer
by: Ruiheng Wang, et al.
Published: (2025-01-01)

Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer
by: Tianle Zou, et al.
Published: (2023-01-01)

Tiptoeing on Metastatic Adenocarcinoma of the Lung
by: Arupreet Kochar, et al.
Published: (2019-01-01)

Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System
by: Chundi Gao, et al.
Published: (2022-01-01)

A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes
by: Zhen Xiong, et al.
Published: (2022-01-01)

Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma
by: Licheng Li, et al.
Published: (2022-01-01)

A prognostic signature of Glutathione metabolism-associated long non-coding RNAs for lung adenocarcinoma with immune microenvironment insights
by: Junxi Hu, et al.
Published: (2025-02-01)

Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer
by: Chunyan Wei, et al.
Published: (2021-01-01)

Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity
by: Jinzhi Lai, et al.
Published: (2025-01-01)

Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
by: Qian Zhu, et al.
Published: (2025-01-01)

Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
by: Wei Tan, et al.
Published: (2025-01-01)